Schistosomiasis is an infectious disease caused by parasitic worms that affects more than 210-million people, predominantly in developing countries. Its main pathological feature is a pro-inflammatory reaction to the parasite eggs that are trapped in tissues or organs, with subsequent formation of hepatic granulomas (nodules of immune cells) and fibrosis, processes against which current treatments are often inefficacious. Recent data showed that the chemokine Cx3cr1, expressed by macrophages, promotes fibrotic processes. Thus, Cong-Yi Wang and colleagues sought to investigate whether reducing Cx3cr1 signalling in infiltrating macrophages can prevent hepatic granulomas in Schistosoma japonicum-infected mice – a well-established model of human schistosomiasis. The group found that S. japonicum infection increased the expression of Cx3cr1 in infiltrating macrophages, whereas lack of the Cx3cr1 gene prevented egg-induced granuloma formation and hepatic injury in the animals. Interestingly, loss of Cx3cr1 induced M2 polarisation of macrophages, a process that enhances the helper-T-cell-2 (Th2) response, a key T-cell-mediated pro-inflammatory reaction against intracellular parasites. These results suggest CX3CR1 as a viable therapeutic target for the treatment of human schistosomiasis. Page 691
CX3R1 signalling attenuates hepatic damage in schistosomiasis
- Split-screen
- Views Icon Views
-
Article Versions Icon
Versions
- Version of Record 01 July 2015
- Share Icon Share
-
Tools Icon
Tools
- Search Site
CX3R1 signalling attenuates hepatic damage in schistosomiasis. Dis Model Mech 1 July 2015; 8 (7): e0701. doi:
Download citation file:
Advertisement
Cited by
Special Issue: The RAS Pathway

Our latest special issue is now complete. It showcases RAS-driven mechanisms of disease progression, and highlights approaches to treat and modify the disease course in model systems.
Call for papers: Moving Heart Failure to Heart Success

Disease Models & Mechanisms is pleased to welcome submissions for consideration for an upcoming special issue, Moving Heart Failure to Heart Success: Mechanisms, Regeneration & Therapy. The deadline for submitting articles to the special issue has been extended to 1 August 2022.
Propose a new Workshop

Our Workshops bring together leading experts and early-career researchers from a range of scientific backgrounds. Applications are now open to propose Workshops for 2024, one of which will be held in a Global South country. .
A focus on Drosophila

In a series of front section articles, DMM is highlighting the versatility, breadth, and scope of Drosophila research in human disease modelling and translational medicine.
Apply for a DMM Conference Travel Grant

Aimed at early-career researchers wanting to attend in-person and virtual meetings, the next application deadline for a DMM Conference Travel Grant is 6 June 2022. Find out more and hear from past recipients about their experience of the grant.
Other journals from
The Company of Biologists